Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →
logo
Get CLEATUS

SUMATRIPTAN SUCCINATE

Active
SPE2DP-26-T-4473Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Sumatriptan Succinate Tablets, 100mg, are supplied in bottles of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at 20 to 25°C (68 to 77°F) and protected from light, complying with USP controlled room temperature standards. It is subject to a non-extendable 24-month shelf life under Type I (Code M) requirements, with packaging and marking mandated to adhere to MIL-STD-2073-1E and MIL-STD-129, as well as the latest Medical Marking Standard No. 1. The supply is regulated by the FDA, and contractors must provide detailed manufacturer and product information for official verification. Two line items total two bottles, with delivery required within five days to two separate military addresses: one at Joint Base Elmendorf-Richardson, Alaska, and the other at Ramstein Air Base, Germany. Both shipments are FOB destination, with zero variance allowed in quantity, and inspection and acceptance occur at the delivery point. The contract includes DLA-specific packaging, procurement, and logistics requirements, referencing technical standards from the DLA Master List, and is issued under solicitation SPE2DP-26-T-4473 with a required delivery date of August 5–6, 2026.

General Info

100mg sumatriptan tablets, two bottles, FOB destination, delivered August 5–6, 2026, to Alaska and Germany.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325411 - Medicinal and Botanical ManufacturingView NAICS

Place of Performance

5250 GIBSON AVE BLDG 5250, JBER, AK, 99506-4400, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4473.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts
Vanesa M Carbo Acevedo
contact@example.gov
+1 (555) 000-0000

Full Description

Show more
SUMATRIPTAN SUCCINATE TABLETS
SUMATRIPTAN SUCCINA
SUMATRIPTAN SUCCINATE TABLETS, 100MG BOTTLE OF 9 TABLETS. STORE AT 20
TO 25 C (68 TO 77 F). [SEE USP CONTROLLED ROOM TEMPERATURE.]PROTECT
FROM LIGHT. INDICATED FOR THE ACUTE TREATMENT OF MIGRAINE WITH OR
WITHOUT AURA IN ADULTS.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
GOLDEN STATE MEDICAL SUPPLY, INC. 1HT23 P/N NDC51407-0013-09 MYLAN PHARMACEUTICALS INC 3KJG9 P/N NDC00378-5632-59
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
SPE2DP-26-T-4473
SECTION B
PR: 7017739030 PRLI: 0001 CONT’D
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017739030 0001 BT 2.000
NSN/MATERIAL:6505017278704
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
FM5000
FM5000 673 MDSS SGSM
5250 GIBSON AVE BLDG 5250
JBER AK 99506-4400
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
FM5000
FM5000 673 MDSS SGSM
CP 907 552 8846
5250 GIBSON AVE BLDG 5250
JBER AK 99506
US
M/F: (TCN) FM500062150041
RDD:
PROJ: TP 1
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 03
SPE2DP-26-T-4473
SECTION B
PR: 7017739030 PRLI: 0001 CONT’D
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:08/06/2026
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0002 7017715076 0001 BT 1.000
NSN/MATERIAL:6505017278704
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
PKGING DATA MIL-STD-2073-1E QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z UNIT CONT:ZZ OPI:M INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ PACK CODE:Z PACKING LEVEL: B MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129. SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a
SPE2DP-26-T-4473
SECTION B
PR: 7017715076 PRLI: 0001 CONT’D
shelf life of 24 months (non-extendable) applies to this item.
Shall be marked IAW the latest edition of Medical Marking Standard No. 1 https://www.dla.mil/Logistics-Operations/Packaging/
PARCEL POST ADDRESS:
FM5612
FM5612 86 MDSS SGSM
UNIT 2497 CP 011 496 371 46 2418
APO AE 09094-3219
US
FOR TRANSPORTATION SEE DLAD DLAD PROC NOTE C19. FOR FIRST DESTINATION TRANSPORTATION SEE DLAD PROC NOTE
C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
FM5612
FM5612 86 MDSS SGSM
UNIT 3219BLDG 2497 CP 0110114963714
LINCOLN BLVD RAMSTEIN FLUGPLATZ
RAMSTEIN 66877
DE
M/F: (TCN) FM561262120293
RDD:
PROJ: TP 3
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 13
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:08/05/2026
SPE2DP-26-T-4473 NSN/Part Number: 6505-01-727-8704 Quantity: 2 BT Purchase Request: 7017715076QTY: 1 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325411
New
DIBBS
CALCIUM CHLORIDE INJEC
Solicitation # SPE2DP-26-T-4471
CALCIUM CHLORIDE INJECTION USP is procured as a 10 mL single-dose plastic syringe containing 1 gram of calcium chloride (100 mg/mL), packaged ten syringes per unit (1 PG = 10 EA), with a mandatory 24-month shelf life from the date of manufacture, no less than 21 months of which must remain at the time of delivery to the government. The product must be labeled in strict accordance with Medical Marking Standard No. 1, including the NSN, manufacturer, CAGE code, date of manufacture, expiration or retest date, contract number, and lot number, and stored at 20 to 25°C (68 to 77°F). The item is regulated by the FDA and requires prior confirmation from the product specialist via EBS referral before award. Packaging must be commercial and designed to protect against damage, with exterior shipping containers ensuring safe, cost-effective transport to the delivery point. All packaging and marking must comply with Medical Marking Standard No. 1, superseding MIL-STD-129, and palletization must follow DLA Packaging Requirements for Procurement. The manufacturer is Pfizer Inc, with NDC 00409-1631-10, and the item is identified by NSN 6505-01-655-0700. Delivery is FOB destination in 20 days to Fort Campbell, Kentucky, with zero quantity variance permitted, and shipment must occur via traceable means, excluding parcel post. The contract reference is SPE2DP-26-T-4471, with an original required delivery date of August 5, 2026, and procurement governed by the DLA Master List of Technical and Quality Requirements, which take precedence over all other standards including ASTM D3951.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
MAGNESIUM SULFATE
Solicitation # SPE2DP-26-T-4456
MAGNESIUM SULFATE 495MG/5GM oral granules in 454GM bags, sold in cases of 12 bags each, is procured under contract SPE2DP-26-T-4456 for delivery to the USS THEODORE ROOSEVELT CVN 71 at FPO AP 96632 with a five-day delivery window and no tolerance for quantity variance. The product is classified as a TYPE I (CODE Q) medical item with a non-extendable shelf life of 36 months and must comply with Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. All packaging must meet commercial standards as specified in DLA’s procurement requirements, ensuring each unit is sealed in protective containers and packed in exterior shipping containers suitable for safe, low-cost transport by common carrier to the destination. Palletization and labeling must adhere to DLA’s Packaging Requirements for Procurement and the latest version of Medical Marking Standard No. 1, available through DLA Troop Support or their official website. The item is identified by NSN 6505-01-714-4975 and NDC 46122-0461-43, supplied by AMERISOURCEBERGEN DRUG CORP, and shipped via traceable methods only—parcel post is prohibited. Delivery is FOB destination with inspection and acceptance also occurring at the point of delivery, and the required delivery date is August 5, 2026.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
Manufacturing of CARD Casualty Response Documentation ToolThe contract is for the full production of a durable, field-ready medical documentation card designed to support casualty response operations, adhering strictly to the DLA Master List technical and quality standards. The product must be robust enough for frontline use under demanding conditions and capable of reliably conveying critical medical information in austere environments. Production will be executed as a subcontract under the Department of Defense’s Medical Supply Chain MD Surg FSF, with the place of performance located in WaterVliet, New York, at the ZIP code 12189-5000. The NAICS code 325411 indicates the work falls under pharmaceutical and medicine manufacturing, underscoring the precision and regulatory compliance required in materials and processes. The solicitation was posted on August 2, 2026, with a response deadline of August 10, 2026, allowing potential subcontractors a limited window to submit proposals. The contract type is explicitly labeled as a subcontract, meaning the winning party will be engaged by a prime contractor rather than directly by the government. There is no set-aside classification specified, indicating the opportunity is open to all eligible entities regardless of business size or status. While no point of contact is listed, interested parties can access additional details through the provided DIBBS link, which hosts the official request for quotation. The focus is squarely on delivering a standardized, high-integrity medical documentation tool that meets rigorous military specifications for reliability and performance.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
Supply of Hydrocortisone Cream 2.5% (NSN 6505017157536)The contract entails the procurement and delivery of ten units of Hydrocortisone Cream 2.5% in one-ounce tubes, specifically designated by NSN 6505017157536, ensuring full compliance with FDA regulations and adherence to Department of Defense medical and logistical standards as defined by DLA. All products must meet stringent military medical requirements for quality, packaging, labeling, and shelf life to support operational readiness and field distribution. The solicitation is issued under a subcontract mechanism with a NAICS code of 325411, indicating pharmaceutical manufacturing, and is managed by the Medical Supply Chain Pharm FSA under the Department of Defense. Responses are due by August 10, 2026, with the opportunity posted on August 2, 2026, providing suppliers eight days to submit proposals. The place of performance and point of contact details are not specified, but delivery must fulfill the logistical needs of the Defense Logistics Agency. The contract is accessible through the DIBBS platform, and while no set-aside designation is listed, all offerings must be FDA-approved and aligned with the prescribed military medical specifications for use in deployed and garrison medical facilities.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
Supplier of Omeprazole Extended-Release Capsules (NSN 6505016247068)The contract solicits suppliers to provide FDA-approved Omeprazole Extended-Release Capsules in bulk quantities that fully comply with National Stock Number NSN 6505016247068 specifications, ensuring eligibility for procurement by the Defense Logistics Agency. The product must meet all regulatory and quality standards required for use within U.S. military medical supply chains and is intended for distribution through the Department of Defense’s Medical Supply Chain Pharmaceutical FSA. Submission deadlines are firm, with responses due by August 10, 2026, and the solicitation is structured as a subcontract under the NAICS code 325411, which pertains to pharmaceutical and biological product manufacturing. All deliveries are to be addressed to the designated place of performance in APO, ZIP 96264-2022, with no additional office address details provided. The contract is posted on the DIBBS platform and is open to qualified manufacturers capable of meeting stringent military pharmaceutical requirements.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
Supply of NSN 6505-01-719-3181 Medical or Hazardous ItemThe contract requires the supply of a commercial item identified by NSN 6505-01-719-3181, which must meet all applicable medical, packaging, and hazardous material regulations. This item is intended for use within the Department of Defense’s medical supply chain and must be delivered in full compliance with federal standards for handling and transport of sensitive medical or hazardous goods. The work is to be performed at FPO with a ZIP code of 96675, and the contract is classified as a subcontract under NAICS code 325411, indicating the manufacturing of pharmaceutical and botanical products. The solicitation was posted on August 2, 2026, with responses due by August 10, 2026, and the official interface for details can be accessed through the DLA Dibbs platform.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
Supplier of Sodium Chloride Injection and Medical ConsumablesThe contract seeks a supplier to provide FDA-regulated sodium chloride injection syringes and related medical consumables that comply with strict shelf-life and packaging standards required for military medical use. The items must meet regulatory and quality benchmarks to ensure safety, sterility, and operational readiness within Department of Defense healthcare systems. Performance is scheduled to be fulfilled at the WaterVliet location with zip code 12189-5000, indicating the physical delivery point for these critical medical supplies. This is a subcontract opportunity issued under the NAICS code 325411 for pharmaceutical manufacturing and was posted on August 2, 2026, with responses due by August 10, 2026. It is managed by the Medical Supply Chain Pharm FSA under the Department of Defense and is part of the broader effort to maintain reliable, high-integrity medical inventory for U.S. military operations. Suppliers must adhere to all federal medical device and pharmaceutical regulations and deliver fully compliant products to support the readiness of deployed medical teams.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
PSYLLIUM HYDROPHILIC M
Solicitation # SPE2DP-26-T-4405
The contract is for the procurement of Psyllium Hydrophilic Mucilloid in 12-gram packets, each containing 25 mg of potassium and 5 mg of sodium, packaged in units of 30 packets per case. This product is regulated by the FDA and must be supplied with its manufacturer’s part number NDC37000-0740-87, sourced from Procter & Gamble Distributing LLC. The item has a non-extendable shelf life of 24 months and must comply with DLA’s technical and quality requirements as defined in the DLA Master List, with packaging and marking strictly governed by Medical Marking Standard No. 1, which supersedes all references to MIL-STD-129. Packaging must meet MIL-STD-2073-1E and DLA-specific packaging requirements, ensuring secure, commercial-grade containment capable of protecting contents during transit. Delivery is FOB destination with no tolerance for quantity variance, and items must be shipped within five days of contract award using the fastest traceable means—parcel post is prohibited. The delivery address is a Navy vessel in FPO AP 96675, with specific shipping and marking instructions governed by DLA’s logistics protocols. The NSN is 6505-01-719-3181, and the contract number is SPE2DP-26-T-4405, with an original required delivery date of August 4, 2026. All bids must include the supplier and manufacturer details for FDA referral through EBS prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
SUMATRIPTAN SUCCINATE
Solicitation # SPE2DP-26-T-4415
Sumatriptan Succinate Tablets, 100 mg, are supplied in a bottle of nine tablets and are indicated for the acute treatment of migraine with or without aura in adults. The product must be stored at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from light, in compliance with USP standards. The item is regulated by the FDA and subject to strict shelf-life requirements: it has a non-extendable shelf life of 24 months as a Type I CODE M item, and must be marked according to the latest edition of Medical Marking Standard No. 1 and MIL-STD-129 for packaging and labeling. Packaging and palletization must adhere to DLA’s Packaging Requirements for Procurement and MIL-STD-2073-1E, with no tolerance for quantity variance. The contract specifies delivery FOB destination within 20 days, with inspection and acceptance occurring at the destination. The supplier is identified as MYLAN PHARMACEUTICALS INC with NDC 00378-5632-59, and the item is procured under NSN 6505-01-727-8704. Delivery is to a U.S. military address in APO AE 09094-3219, with freight originating from Ramstein, Germany. The solicitation number is SPE2DP-26-T-4415, with a required delivery date of August 4, 2026, and bid responses due by August 10, 2026. Technical and quality requirements are governed by the DLA Master List, and the contracting official must submit a referral through EBS for FDA product validation prior to award.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
CARD CASUALTY RESPO
Solicitation # SPE2DS-26-T-298R
The CARD CASUALTY RESPONSE DOCUMENTATION TOOL is a compact, durable card measuring 6.5 inches by 4 and 2/8 inches, constructed from card stock with a grommet and sealed in clear plastic for protection, accompanied by a 14-inch cable tie to securely fasten it to the patient. Designed for frontline responders, it captures essential data elements required for initial casualty treatment documentation. Each card includes a unique individual bar code identifier to ensure accurate tracking and record linkage. The unit of issue is singular, and the item is designated by NSN 6515-01-575-2772 with a procurement quantity of 8 units under purchase request 7017710965. Delivery is required within five days of award, with performance occurring in WaterVliet, New York, 12189-5000. The contract, issued under solicitation SPE2DS-26-T-298R, is subject to technical and quality requirements from the DLA Master List, with compliance dependent on the revision in effect at the solicitation or award date. It falls under NAICS code 325411 and is managed by the Department of Defense’s Medical Supply Chain MD Surg FSF. The item is classified as potentially containing covered defense information, and packaging must follow DLA procurement standards. Government identification must be removed from non-accepted supplies, and bidders are required to specify their source and part number. All submissions must be made prior to the response deadline of August 10, 2026, with the solicitation posted on August 2, 2026.
MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
HYDROCORTISONE CREA
Solicitation # SPE2DP-26-T-4438
The contract specifies the procurement of 10 units of Hydrocortisone Cream 2.5% in 1 oz tubes, manufactured by Sun Pharmaceutical Industries, Inc., with NDC number 10631-0407-01. Each unit must be packaged in compliance with the Medical Marking Standard No. 1 and MIL-STD-2073-1E, with all labeling and marking requirements strictly followed, superseding any reference to MIL-STD-129. The product is regulated by the FDA and requires a 24-month non-extendable shelf life, with storage conditions maintained at controlled room temperature between 20 to 25°C (68 to 77°F) and protected from freezing. Delivery is required FOB destination within five days of contract award, with no variance allowed in quantity, and inspection and acceptance occur at the delivery point. The shipment must be sent by the fastest traceable means, excluding parcel post, to Fort Stewart, Georgia, under the solicitation number SPE2DP-26-T-4438. Packaging must ensure safe transit via commercial carriers at the lowest cost, with each unit sealed and protected from damage. All technical and quality requirements are governed by the DLA Master List, and the contract incorporates specific DLA packaging directives including RP001 and RD003. The contract is issued under a federal procurement system with a unit of issue of EA and a total value of $10.00.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details
NAICS: 325411
New
DIBBS
LIDOCAINE HYDROCHLO
Solicitation # SPE2DP-26-T-4430
The contract specifies the procurement of LidoCaine Hydrochloride 2% Mucosal Jelly in single-use prefilled plastic syringes, each containing 220 mg per 11 mL, packaged in boxes of ten units. The product is a sterile topical anesthetic intended for medical use, with a non-extendable shelf life of 36 months and must comply with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards as defined in the procurement document, ensuring each unit is sealed and protected from damage, and shipped in commercial exterior containers that guarantee safe delivery at the lowest cost to the designated destination. The item is identified by NSN 6505-01-707-4169 and NDC 25021-0673-77, supplied by Sagent Pharmaceuticals, Inc., and the unit of issue is one box containing ten syringes. Delivery is required within five days FOB destination, with no variance permitted in quantity, and inspection and acceptance occur at the delivery point. The shipment is directed to USMC facilities in Palmerston, Australia, under a SOFA tariff agreement, with specific transportation and marking instructions governed by DLA procedures. The contract was issued under solicitation SPE2DP-26-T-4430, with a response deadline in August 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy McCauley listed as the primary point of contact.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 325412
New
DIBBS
BUPIVACAINE AND EPINEP
Solicitation # SPE2DP-26-T-4478
The contract specifies the procurement of Bupivacaine and Epinephrine Injection, containing 0.500% w/v Bupivacaine HCl and 0.005 mg Epinephrine per mL (1:200,000), packaged in 1.8 mL cartridges, with a unit of issue of one case containing 50 cartridges. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and must have a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an 18-month maximum shelf life. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be commercially packaged to ensure safe transit under ASTM D3951 or applicable hazardous material standards if classified as hazardous under FED-STD-313. The supply must be free of intentional mercury or mercury compounds, except where functionally necessary and explicitly exempted, and any permitted mercury-containing components must meet Navy shockproof and secondary containment requirements. Delivery is required FOB destination within 20 days to the USS Delaware (SSN 791) at FPO AE 09583, with no variance allowed in quantity, and shipment must use traceable, expedited methods with no parcel post. The item is identified by NSN 6505-01-189-3973 and purchase request 7017729383, with a required delivery date of August 6, 2026. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, which supersedes any conflicting standards.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
VERAPAMIL HYDROCHLO
Solicitation # SPE2DP-26-T-4480
Verapamil Hydrochloride Extended-Release Tablets, 240 mg, are being procured in bottles of 100 tablets each, with a total quantity of two bottles required under contract SPE2DP-26-T-4480. The product must have a minimum of 31 months of shelf life remaining at the time of delivery, with a full 36-month shelf life specified and non-extendable. Packaging must comply strictly with DLA Packaging Requirements for Procurement and the latest Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection from damage during transit. All units must be commercially packaged in suitable exterior shipping containers, meeting the lowest freight rate standard for delivery to the specified destination. The item is regulated by the FDA, and the contracting official must confirm compliance via EBS referral. Manufacturer and distributor information includes Glenmark Pharmaceuticals Inc., USA and Cardinal Health 200, LLC, with the NDC number NDC68462-0260-01. The delivery is FOB destination, with a 20-day delivery window and no quantity variance permitted. Shipment must be traceable and cannot be sent via parcel post; instead, it must be transported using the FASTEST TRACEABLE MEANS with RDD 777 and referenced to the DLA vendor code V23027. The required delivery date is February 17, 2026, and the item is to be delivered to USS IWO JIMA LHD 7, FPO AA 34094. All packaging, labeling, and documentation must adhere to applicable DLA technical and quality requirements listed in the DLA Master List, which take precedence over ASTM D3951 and other commercial standards.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
ALBUTEROL INHALATIO
Solicitation # SPE2DP-26-T-4470
Albuterol Inhalation Aerosol is a prescription-only medication supplied as a pressurized aluminum canister containing 60 actuations, each delivering 108 micrograms of albuterol sulfate, equivalent to 90 micrograms of albuterol base, through a plastic actuator with a strap cap and built-in counter. The canister has a net weight of 8 grams and must be stored at 20° to 25°C (68° to 77°F), with allowable excursions between 15° and 30°C, following USP controlled room temperature guidelines. The inhaler must be kept with the mouthpiece down, shaken well before each use, and brought to room temperature prior to administration to ensure optimal performance. The product has a non-extendable shelf life of 18 months, and at the time of receipt by the first government activity, a minimum of 15 months of shelf life must remain. It is labeled and marked in compliance with SPE2DP-26-T-4470 and Medical Marking Standard No. 1C, and is classified as a hazardous material with flammable characteristics due to its pressurized contents. The canister must not be punctured, exposed to temperatures above 120°F, or disposed of in fire or incinerators. A current Material Safety Data Sheet (MSDS) is required and must accompany each shipment, submitted electronically to DLA.MSDS@DLA.MIL along with a completed cover sheet. Packaging must conform to 49 CFR and ICAO regulations for hazardous materials. The NSN is 6505-01-649-7928, with a quantity of 15 units ordered under Purchase Request 7017715897, with delivery required within 20 days of award. The solicitation is governed by DLA technical and quality requirements referenced in the DLA Master List, and buyers must confirm regulatory compliance through an EBS referral to the product specialist, providing manufacturer and bidder details. The item is regulated by the FDA and falls under Defense Information potentially subject to additional reporting.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
PERMETHRIN CREAM RINSE
Solicitation # SPE2DP-26-T-4477
Permectrin Cream Rinse is a 1% w/v topical medication packaged as a 2 fl oz plastic squeeze bottle, each unit including a comb for application, and supplied in individual units with a minimum of 21 months of remaining shelf life at time of receipt by the government, ensuring a 24-month total shelf life is maintained. The item is regulated by the FDA and must comply with all applicable medical, packaging, and hazardous materials standards including Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging requirements that ensure protection from damage during shipping and compliance with commercial standards for both interior and exterior containers. All shipments must include a current Safety Data Sheet (SDS) formatted per 29 C.F.R. 1910.1200, with labels meeting OSHA’s Hazard Communication Standard and the Globally Harmonized System, and these documents must be submitted for approval before contract award. Each shipment must also carry a copy of the SDS and be marked in accordance with the approved medical marking guidelines. The product is subject to DLA’s technical and quality requirements as outlined in the DLA Master List, and must comply with all applicable transportation regulations including 49 CFR and ICAO standards for hazardous materials. The NSN is 6505-01-256-4972, with two units requested under solicitation SPE2DP-26-T-4477, with a 20-day delivery requirement and a contract awarded to a government activity under the Department of Defense.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
GLOBULIN, RHO (D) IMMUN
Solicitation # SPE2DP-26-T-4482
GLOBULIN RHO (D) IMMUNE, USP, 300 MICROGRAMS per 1ML disposable syringe with safety mechanism, is intended for intramuscular injection only and is designated for adult use. The product must be stored at 2 to 8 degrees Celsius and must not be frozen. It is a prescription-only item and packaged individually as a single unit. The item is regulated by the FDA and requires confirmation through the EBS referral system, including submission of bidder and manufacturer details. The NSN is 6505-01-417-1250, and it is subject to DLA packaging and technical requirements referenced in the DLA Master List of Technical and Quality Requirements. As a hazardous material, it requires a current Material Safety Data Sheet (MSDS) to be submitted to DLA.MSDS@DLA.MIL and physically included with each shipment, with packaging compliant with 49 CFR and ICAO regulations. This solicitation, issued under SPE2DP-26-T-4482 by the Department of Defense’s Medical Supply Chain PHARM FSA, has a response deadline of August 10, 2026, with a delivery requirement of 20 days after award. The point of contact for inquiries is James Foggie, with email and phone provided for coordination.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
APPLICATOR, SILVER NITR
Solicitation # SPE2DP-26-T-4469
The applicator consists of a 75% silver nitrate and 25% potassium nitrate mixture fused to one end, measuring six inches or 1.524 centimeters, and is intended for topical use only with a prescription requirement. Each unit of issue is a container holding 100 applicators, which must be stored in the original closed package at room temperature in a dark, dry location, away from organic or oxidizable materials. The item is classified as a Type I (Code M) shelf-life item with a non-extendable shelf life of 24 months. It is regulated by the FDA, and buyers must submit a referral in EBS to confirm product details including bidder and manufacturer information. Hazardous materials regulations apply, requiring a current MSDS to be submitted via DLA.MSDS@DLA.MIL and included with each shipment, with packaging compliant to SPE2DP-26-T-4469 and applicable 49 CFR and ICAO standards. Removal of government identification from non-accepted supplies is required, and covered defense information potentially applies. The NSN is 6505-00-299-9672, with a single contract order quantity and a 10-day delivery requirement after award. The solicitation, issued under SPE2DP-26-T-4469, was posted on August 4, 2026, with responses due by August 10, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Nicholas Quigley listed as the primary point of contact.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 424210
New
DIBBS
LIDOCAINE AND PRILOCAI
Solicitation # SPE2DP-26-T-4475
Lidocaine and prilocaine periodontal gel, marketed as ORAQIX at a 2.5%/2.5% concentration, is a microemulsion dental anesthetic supplied in individual blister-packed cartridges, each containing 1.7 grams of gel, with 20 cartridges per carton. Each cartridge comes with a single-use sterile blunt-tipped applicator and must be stored at controlled room temperature between 20°C and 25°C. The product is regulated by the FDA and classified as a prescription-only device with a non-extendable shelf life of 36 months, requiring labeling in compliance with MMS No. 1. Packaging must conform to DLA specifications, including MIL-STD-129 marking, and all technical and quality requirements from the DLA Master List take precedence over commercial standards. The item is identified by NSN 6505-01-656-9640 and manufacturer part number NDC66312-0110-20 from Dentsply Sirona Inc. The contract, issued under solicitation SPE2DP-26-T-4475, requires delivery of three packages to Seymour Johnson Air Force Base in North Carolina within 20 days of order placement, with FOB destination terms and zero tolerance for quantity variance. Shipping must be conducted via traceable means, explicitly prohibiting parcel post. The delivery is scheduled for August 5, 2026, and the contract includes federal acquisition compliance requirements, including referral protocols for FDA-regulated items through EBS and adherence to covered defense information protocols. The purchasing request number is 7017708438, and all packaging and unit of issue must align with DLA’s authorized standards, with point of contact Lawrence Garnett available for coordination.
Drugs and Druggists' Sundries Merchant Wholesalers

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
HYDROGEN PEROXIDE TOPI
Solicitation # SPE2DP-26-T-4481
Hydrogen Peroxide Topical Solution USP RP001 is a 3% stabilized solution intended for external topical use only, not for ingestion or application to the eyes or large body areas, and must not be used for more than one week. Each unit of issue is a 473-milliliter bottle, requiring tight closure, storage at controlled room temperature, protection from freezing and excessive heat, and must not be shaken. Labeling and packaging must strictly comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and all packaging must be commercially sealed and designed to prevent damage during transport. The item is regulated by the FDA and classified as a TYPE I (CODE M) item with a non-extendable shelf life of 24 months. As a hazardous material under OSHA’s revised Hazard Communication Standard effective June 1, 2015, suppliers must provide Safety Data Sheets (SDS) and compliant HCS labels per 29 C.F.R. 1910.1200, and must train employees on these requirements. The contract mandates delivery within 20 days to FPO AP 96693, FOB destination, with zero variance in quantity, and prohibits parcel post in favor of traceable shipping methods. The NSN is 6505-00-153-8480, with a contracted quantity of two bottles, procured under solicitation SPE2DP-26-T-4481, and all technical and quality requirements are governed by the DLA Master List, which supersedes ASTM D3951. Approved manufacturers include Medline Industries, LP, Cardinal Health 200, LLC, and McKesson Medical-Surgical Government, with the item identified by multiple NDC and part numbers. All deliveries must be palletized per RP001 requirements and marked per Medical Marking Standard No. 1.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
TOLNAFTATE POWDER, U
Solicitation # SPE2DP-26-T-4483
The contract specifies the procurement of 6 units of TOLNAFTATE POWDER, USP 1%, each unit being 45 grams, for delivery to a U.S. military vessel at FPO AP 96693. The item, identified by NSN 6505-01-480-7897 and NDC 57896-0199-45, must comply with stringent packaging and labeling requirements, including adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and must be commercially packaged in accordance with ASTM D3951 unless specified otherwise by DLA Master List requirements. The product has a non-extendable shelf life of 36 months and must be labeled and marked according to federal medical standards. Delivery is due within 20 days of contract award, with a firm fixed price and zero variance allowed in quantity. Freight must be shipped via the fastest traceable means—parcel post is prohibited—and transportation must follow DLA Procurement Notes C19 and C20. The contract requires FOB destination delivery, with inspection and acceptance occurring at the final destination. All packaging and palletization must conform to DLA Packaging Requirements for Procurement, and the supplier, GERI-CARE PHARMACEUTICALS CORP., must ensure compliance with all technical and quality specifications outlined in the DLA Master List. The solicitation was issued on August 4, 2026, with a response deadline of August 10, 2026, under contract number SPE2DP-26-T-4483.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENT
Solicitation # SPE2DP-26-T-4472
Dibucaine Ointment USP is a topical pharmaceutical product containing one percent dibucaine as the active ingredient, designed for rectal administration and external use only. It is supplied in a collapsible tube and includes a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of ointment. The product must be stored at temperatures between 15 and 30 degrees Celsius or 59 to 86 degrees Fahrenheit to maintain stability and efficacy. This item has a non-extendable shelf life of 36 months and must be marked in accordance with the latest edition of the Medical Marking Standard No. 1. It is regulated by the FDA and classified as a Type I (Code Q) pharmaceutical item with specific supply chain requirements under DLA standards. The contract, issued under solicitation number SPE2DP-26-T-4472, requires delivery of five packages (PG) to be shipped FOB destination within ten days. The quantity variance is strictly zero percent, meaning exact fulfillment is mandatory. Inspection and acceptance occur at the destination, and packaging must comply with MIL-STD-2073-1E. The NSN is 6505-00-299-9535 and the manufacturer part number is NDC00536-1211-95, supplied by The Harvard Drug Group, L.L.C. All procurement activities are governed by DLA technical and quality requirements referenced in the DLA Master List, and the contracting official must submit an EBS referral to confirm regulatory compliance before award. The point of contact for the solicitation is Alec Deichman, and the place of performance is San Antonio, Texas.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details
NAICS: 325412
New
DIBBS
MOXIFLOXACIN HYDROC
Solicitation # SPE2DP-26-T-4476
Moxifloxacin Hydrochloride Tablets, 400 mg in 30-count bottles, are procured under solicitation SPE2DP-26-T-4476 for delivery to the Navy Expeditionary Central Facility in Williamsburg, VA, with a required delivery window of 20 days. The contract specifies a total quantity of 24 bottles, each containing 30 tablets, with a unit price of $24.00 per bottle and no variance allowed in quantity. The product must comply with stringent packaging and labeling standards as defined by Medical Marking Standard No. 1, superseding MIL-STD-129, and must be shipped in commercial, durable containers that ensure safe transport via common carrier at the lowest cost. Shelf life is strictly limited to 36 months and non-extendable, with storage required at controlled room temperature and protection from high humidity. The item is regulated by the FDA, and bidders must provide full manufacturer details including NDC numbers, with TEVA PHARMACEUTICALS USA, INC. and RISING PHARMA HOLDINGS, INC. identified as potential suppliers. All packaging, marking, and shipment must adhere to DLA’s Master List of Technical and Quality Requirements, and hazardous material provisions apply as per FED-STD-313 and ASTM D3951 where applicable. Shipment must be made by the fastest traceable means, excluding parcel post, and must be palletized per RP001 requirements. The contract mandates delivery FOB destination, with inspection and acceptance occurring upon receipt at the delivery point, and all documentation must reflect compliance with DLA’s unit of issue and procurement standards.
Pharmaceutical Preparation Manufacturing

POSTED

about 9 hours ago

DEADLINE

in 6 days
View Details